Amboss vs Owkin

Amboss is a medical knowledge platform used by students and clinicians worldwide — combining a continuously updated clinical library, exam-prep question banks, and point-of-care reference in one system, increasingly enhanced with AI features.

For students, it's exam infrastructure: tens of thousands of USMLE/exam-style questions with detailed explanations, adaptive study planning, and a library where any medical term links to a full article. For practicing clinicians, it's a fast bedside reference with evidence-based guidance, drug information and diagnostic support. AI features assist with search, explanation and study efficiency, layered on human-curated medical content.

Subscription…

Owkin is an AI biotechnology company that uses multimodal patient data to advance drug discovery, diagnostics, and precision medicine. Its federated learning platform enables healthcare institutions and pharmaceutical companies to collaborate on research while preserving patient privacy. Owkin combines clinical, imaging, genomic, and molecular data to identify biomarkers and predict treatment outcomes. The company partners with leading health systems and biopharma organizations to develop AI-powered therapeutics and companion diagnostics. Its solutions support oncology, immunology, and rare disease research.